PCP. Van Cauwenberge

P. Van Cauwenberge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


P. Van Cauwenberge has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2008
      • Vol. 70, 305-22

    Chronic rhinonsinusitis and nasal polyposis: the etiopathogenesis revealed?

    by P Van Cauwenberge, T Van Zele, C Bachert

    Nasal polyps represent a severe eosinophilic inflammation of the upper airways which is characterized by poor impact of therapeutic intervention and frequent recurrences. Based on distinct cytokine, mediator and cell profiles, chronic sinonasal disease in Caucasians can be differentiated into several subgroups such as chronic rhinosinusitis without nasal polyps, chronic rhinosinusitis with nasal polyps, and nasal polyps in cystic fibrosis patients,. In Caucasians, nasal polyps showed a Th2 polarisation with high IL-5 concentrations, while chronic rhinosinusitis without polyps was characterized by a Thl polarisation with high levels of IFN-gamma. In the Caucasian nasal polyps we found that significantly more nasal polyp patients are colonized with S. aureus and that colonization increased in patients with concomitant asthma and aspirin sensitivity. Although there was no major difference in the presence of enterotoxin genes in S. aureus strains derived from nasal polyp or control patients, we found an increased immune response to S. aureus enterotoxins in nasal polyps, which resulted in a more pronounced eosinophilic inflammation and higher total IgE production in those polyps affected. We suggest that S. aureus superantigens amplify the inflammation in about 50% of nasal polyps, resulting in a strong Th2 polarisation, eosinophil activation, and an overproduction of IgG4 and IgE. These findings imply new therapeutic approaches apart from the currently used topical and systemic steroid therapy for nasal polyposis. In three double blind placebo controlled studies it was shown that firstly, oral corticosteroids only led to a short term reduction of polyp size. Secondly that a low dose of doxycycline treatment for 20 days had a sustained clinically relevant effect on polyp size for more than 3 months and thirdly we also showed a significant effect on polyp size by selective antagonizing IL-5 with a monoclonal antibody.


  • Staphylococcus-aureus-Enterotoxine bei Atemwegserkrankungen

    by T. van Zele, P. Gevaert, L. de Schrijver, P. van Cauwenberge, C. Bachert

    • 1 September 2003
      • Vol. 41  (3) , 187-91

    Vision impairment as presenting symptom of a sphenoidal mucocele.

    by P Heylbroeck, J B Watelet, P Delbeke, P Van Cauwenberge, C Bachert

    We present a case of a 27-year-old woman with a sphenoid mucocele, presenting with bilateral visual disturbance and pituitary gland dysfunction but without nasal or sinus complaints. We would like to emphasize the importance of early diagnosis and prompt surgical treatment.


  • Global Resources in Allergy (GLORIA): allergic rhinitis and allergic conjunctivitis

    by P. Van Cauwenberge, T. De Belder, J. Vermeiren, A. Kaplan

    Summary: Allergic rhinitis is a common disease, affecting 25–35% of the population. Allergic rhinitis is still increasing in prevalence. It is characterized by rhinorrhoea, itching, sneezing and nasal obstruction. Allergic rhinitis is classically classified into three groups: seasonal (intermittent), perennial (persistent) and occupational allergic rhinitis. In the ARIA document allergic rhinitis is classified into intermittent and persistent. There is a known relationship between allergic rhinitis and asthma, sinusitis, otitis media with effusion, nasal polyposis and upper respiratory tract infections. Allergic rhinitis results from IgE‐mediated allergy, associated with cellular inflammation of the nasal mucosa. The diagnosis of allergic rhinitis is confirmed by a clinical history of typical allergic symptoms and in vivo or in vitro tests for detection of free or cell‐bound IgE. Treatment of allergic rhinitis comprises avoidance of the allergens, oral/nasal antihistamines, decongestants, chromones, ipratropium bromide and intranasal/oral corticosteroids. It is advised to follow the international guidelines, ‘a stepwise approach’. Allergic conjunctivitis is the most common ocular allergic disorder, affecting 5–22% of the population. Ocular allergy involves typical symptoms (itching, watery, stringy or ropey discharge and redness), recurrent/intermittent/persistent episodes, a strong personal and/or family history of atopy and an early age of onset. Treatment of allergic conjunctivitis includes oral/intraocular antihistamines, cromones or topical corticosteroids.


    • 1 December 2000
      • Vol. 55  (6) , 475-7

    Rhinological aspects of cystic fibrosis.

    by J B Watelet, P Van Cauwenberge, C Bachert

    Cystic fibrosis is a genetic disorder of the exocrine glandular function leading to the formation of thick mucus in the nasal and paranasal cavities. Nearly all the patients develop sinus disease but not all have complaints. Two different sinus diseases can be found: chronic sinusitis and nasal polyposis. Only the symptomatic cases have to be treated. Medical treatment consists of antibiotherapy for chronic sinusitis and nasal steroid sprays for nasal polyps. Sinus surgery is frequently needed in case there is a persistence of symptoms (and before lung transplantation).


  • Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

    by P Van Cauwenberge, E F Juniper

    Background: As there have been no previously published studies, this multinational, double‐blind, randomized, placebo‐controlled, parallel group study compared the efficacy, safety and impact on quality of life (QoL) in seasonal allergic rhinitis patients (SAR) of fexofenadine and loratadine (with placebo), when administered once daily.Methods: Six hundred and eighty‐eight SAR patients were randomized to receive fexofenadine HCl 120 mg, loratadine 10 mg or placebo, once daily for 2 weeks. The key parameters were the change from baseline in: mean 24‐h reflective total symptom scores (TSS); sum of four individual symptom scores, excluding nasal congestion; instantaneous TSS; individual symptom scores including nasal congestion; and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Adverse events were recorded.Results: Mean 24‐h reflective and instantaneous TSS were significantly reduced by both fexofenadine HCl (both P ≤ 0.0001) and loratadine (P ≤ 0.001 and P ≤ 0.005, respectively) compared with placebo (n = 639). Among individual symptom scores, fexofenadine HCl was significantly better than loratadine in improving 24‐h reflective itchy, watery, red eyes, as well as relieving nasal congestion (P ≤ 0.05 for both). Fexofenadine HCl was also significantly better than loratadine (P ≤ 0.03) and placebo (P ≤ 0.005) in improving QoL, and the differences were of a magnitude considered to be clinically relevant. Loratadine had no statistically significant effect on QoL compared with placebo. The incidence of adverse events was low and similar across all treatment groups.Conclusion: Fexofenadine HCl and loratadine administered once daily are effective and well tolerated in SAR. In this study, fexofenadine HCl was significantly more effective than loratadine in relieving eye symptoms and nasal congestion. Furthermore, fexofenadine was significantly better than loratadine in improving QoL.


    • 1 January 2000
      • Vol. 54  (2) , 179-89

    Endoscopic endonasal surgery (EES) in skull base repairs and CSF leakage.

    by C Bachert, B Verhaeghe, P Van Cauwenberge, J Daele

    This report aims to summarise the current role of Endoscopic Endonasal Surgery (EES) for skull base and cerebrospinal fluid (CSF) leakage repair, to provide some guidelines for the clinical diagnosis and technical procedures of repair, to demonstrate the limits of this approach and to discuss the Belgian experience of the recent years. Endoscopic surgery for chronic sinus disease is being performed with increasing frequency and CSF leak is an significant potential complication of this surgery, although the incidence of osteo-meningeal perforations in endonasal sinus surgery is below 1% overall. CSF leakage bears the risk of meningeal or intracranial infection and complication and therefore should be repaired as soon as recognised. Following proper localisation of the leak, repair is safely performed in most of the cases by endonasal route with the help of free mucoperiostal flaps taken from the inferior or middle turbinates. This also applies for lesions of other aetiologies. The Belgian data support the statement that the endonasal endoscopic approach is a suitable and successful technique to close CSF leaks in the vast majority of our patients.


    • 1 January 2000
      • Vol. 54  (3) , 397-401

    The common cold.

    by P B Van Cauwenberge, M J Van Kempen, C Bachert

    Upper respiratory tract infections are one of the most common infectious diseases in man and are mainly caused by rhinoviruses. A rhinoviral cold is characterized by a neutrophilic inflammatory reaction with relatively mild symptoms that rather result from the host inflammatory response to the virus than from a direct viral cytotoxic effect. As regulators of chemotaxis, transmigration and activators of inflammatory and immunocompetent cells, cytokines and mediators were shown to play a crucial role in the pathogenesis of a rhinovirus infection.